GMI-1070

· GlycoMimetics Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GMI-1070, covering 2013-05-03 to 2020-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis [Phase 2]